Paris, France

Marielle Chiron-Blonde

This inventor holds 1 USPTO granted patent. Top assignee: Exelixis, Inc.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marielle Chiron-Blonde. Retrieved from https://idiyas.com/inventor/marielle-chiron-blonde

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marielle Chiron-Blonde: Innovator in Cancer Treatment

Introduction

Marielle Chiron-Blonde is a prominent inventor based in Paris, France. She has made significant contributions to the field of cancer treatment through her innovative research and development.

Latest Patents

Marielle holds a patent for "Combinations of kinase inhibitors for the treatment of cancer." This invention provides methods of treating cancer by administering a compound of formula I, optionally as a pharmaceutically acceptable salt, solvate, and/or hydrate thereof, in combination with an inhibitor that targets HER2 and/or HER3. She has 1 patent to her name.

Career Highlights

Marielle is currently associated with Exelixis, Inc., a company known for its focus on developing innovative cancer therapies. Her work has been instrumental in advancing treatment options for patients suffering from various forms of cancer.

Collaborations

Throughout her career, Marielle has collaborated with notable professionals in her field, including Dana T Aftab and Carlos L Arteaga. These collaborations have further enriched her research and contributed to the development of effective cancer treatments.

Conclusion

Marielle Chiron-Blonde is a dedicated inventor whose work in cancer treatment exemplifies the impact of innovation in medicine. Her contributions continue to pave the way for advancements in therapeutic options for cancer patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…